{
    "organizations": [],
    "uuid": "98cf006149d29a32877296c9f8661b00c1d20763",
    "author": "",
    "url": "https://www.reuters.com/article/brief-albireo-announces-agreement-with-h/brief-albireo-announces-agreement-with-healthcare-royalty-partners-idUSFWN1OY0CA",
    "ord_in_thread": 0,
    "title": "BRIEF-Albireo Announces Agreement With Healthcare Royalty Partners",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 08 PM / in 14 minutes BRIEF-Albireo Announces Agreement With Healthcare Royalty Partners Reuters Staff \nJan 3 (Reuters) - Albireo Pharma Inc: \n* ALBIREO ANNOUNCES ROYALTY MONETIZATION AGREEMENT WITH HEALTHCARE ROYALTY PARTNERS FOR ELOBIXIBAT IN JAPAN \n* ALBIREO PHARMA INC - ‍ALBIREO SUBSIDIARY ELIGIBLE TO RECEIVE UP TO $60 MILLION UNDER AGREEMENT​ \n* ALBIREO PHARMA INC - ‍DECISION ON JAPANESE NEW DRUG APPLICATION FOR ELOBIXIBAT EXPECTED IN FIRST HALF OF 2018​ \n* ALBIREO PHARMA -HCR OBTAINS RIGHT TO RECEIVE ROYALTIES, SALES MILESTONES FOR ELOBIXIBAT IN JAPAN THAT MAY BE PAYABLE BY EA PHARMA, UP TO A THRESHOLD​ \n* ALBIREO PHARMA INC - ‍ELOBIX HAS RETAINED ITS RIGHT TO RECEIVE A MILESTONE PAYMENT FROM EA PHARMA IF ELOBIXIBAT IS APPROVED BY MHLW​ \n* ALBIREO PHARMA INC - ‍ IF SPECIFIED THRESHOLD IS REACHED, ELOBIX WILL AGAIN BECOME ELIGIBLE TO RECEIVE ROYALTIES AND SALES MILESTONES FOR ELOBIXIBAT Source text for Eikon:  ",
    "published": "2018-01-03T15:08:00.000+02:00",
    "crawled": "2018-01-03T15:29:03.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "announces",
        "agreement",
        "healthcare",
        "royalty",
        "partner",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "albireo",
        "pharma",
        "inc",
        "albireo",
        "announces",
        "royalty",
        "monetization",
        "agreement",
        "healthcare",
        "royalty",
        "partner",
        "elobixibat",
        "japan",
        "albireo",
        "pharma",
        "inc",
        "subsidiary",
        "eligible",
        "receive",
        "million",
        "albireo",
        "pharma",
        "inc",
        "japanese",
        "new",
        "drug",
        "application",
        "elobixibat",
        "expected",
        "first",
        "half",
        "albireo",
        "pharma",
        "obtains",
        "right",
        "receive",
        "royalty",
        "sale",
        "milestone",
        "elobixibat",
        "japan",
        "may",
        "payable",
        "ea",
        "pharma",
        "albireo",
        "pharma",
        "inc",
        "retained",
        "right",
        "receive",
        "milestone",
        "payment",
        "ea",
        "pharma",
        "elobixibat",
        "approved",
        "albireo",
        "pharma",
        "inc",
        "specified",
        "threshold",
        "reached",
        "elobix",
        "become",
        "eligible",
        "receive",
        "royalty",
        "sale",
        "milestone",
        "elobixibat",
        "source",
        "text",
        "eikon"
    ]
}